Skip to main content
Erschienen in: Critical Care 2/2007

01.04.2007 | Commentary

What does high NT-proBNP mean in septic shock patients? A part of the puzzle

Erschienen in: Critical Care | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

B-type natriuretic peptide (BNP) and amino-terminal pro-BNP (NT-proBNP) plasma levels are commonly high at the early phase of septic shock and have been suggested to be prognostic markers for this condition. It is uncertain, however, whether this increase reflects sepsis related cardiac dysfunction. In a recent issue of Critical Care, Mokart and coworkers showed the accuracy of NT-proBNP in predicting intensive care unit mortality in cancer patients with septic shock, which could help in identifying high risk cancer patients. Results from repeated transthoracic echocardiographs show that NT-proBNP on day 2 after admission was higher in patients presenting with cardiac dysfunction, whereas NT-proBNP on day 1 did not predict cardiac dysfunction. These data suggest that after an initial overexpression of NT-proBNP in all septic patients, patients with cardiac dysfunction will present persistent high levels of NT-proBNP.
Literatur
1.
Zurück zum Zitat Mokart D, Sannini A, Brun JP, Faucher M, Blache JL, Blaise D, Faucher C: NT-proBNP as an early prognostic factor in cancer patients developing septic shock. Crit Care 2007, 11: R37.PubMedCentralCrossRefPubMed Mokart D, Sannini A, Brun JP, Faucher M, Blache JL, Blaise D, Faucher C: NT-proBNP as an early prognostic factor in cancer patients developing septic shock. Crit Care 2007, 11: R37.PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Tung RH, Garcia C, Morss AM, Pino RM, Fifer MA, Thompson BT, Lewandrowski K, Lee-Lewandrowski E, Januzzi JL: Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004, 32: 1643-1647. 10.1097/01.CCM.0000133694.28370.7FCrossRefPubMed Tung RH, Garcia C, Morss AM, Pino RM, Fifer MA, Thompson BT, Lewandrowski K, Lee-Lewandrowski E, Januzzi JL: Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004, 32: 1643-1647. 10.1097/01.CCM.0000133694.28370.7FCrossRefPubMed
3.
Zurück zum Zitat Januzzi JL, Morss A, Tung R, Pino R, Fifer MA, Thompson BT, Lee-Lewandrowski E: Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Crit Care 2006, 10: R37. 10.1186/cc4839PubMedCentralCrossRefPubMed Januzzi JL, Morss A, Tung R, Pino R, Fifer MA, Thompson BT, Lee-Lewandrowski E: Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Crit Care 2006, 10: R37. 10.1186/cc4839PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Chua G, Kang-Hoe L: Marked elevations in N-terminal brain natriuretic peptide levels in septic shock. Crit Care 2004, 8: R248-250. 10.1186/cc2889PubMedCentralCrossRefPubMed Chua G, Kang-Hoe L: Marked elevations in N-terminal brain natriuretic peptide levels in septic shock. Crit Care 2004, 8: R248-250. 10.1186/cc2889PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche JD: Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004, 32: 660-665. 10.1097/01.CCM.0000114827.93410.D8CrossRefPubMed Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche JD: Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004, 32: 660-665. 10.1097/01.CCM.0000114827.93410.D8CrossRefPubMed
6.
Zurück zum Zitat Brueckmann M, Huhle G, Lang S, Haase KK, Bertsch T, Weiss C, Kaden JJ, Putensen C, Borggrefe M, Hoffmann U: Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005, 112: 527-534. 10.1161/CIRCULATIONAHA.104.472050CrossRefPubMed Brueckmann M, Huhle G, Lang S, Haase KK, Bertsch T, Weiss C, Kaden JJ, Putensen C, Borggrefe M, Hoffmann U: Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005, 112: 527-534. 10.1161/CIRCULATIONAHA.104.472050CrossRefPubMed
7.
Zurück zum Zitat Roch A, Allardet-Servent J, Michelet P, Oddoze C, Forel JM, Barrau K, Loundou A, Perrin G, Auffray JP, Portugal H, Papazian L: NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 2005, 33: 1001-1007. 10.1097/01.CCM.0000162561.82012.E9CrossRefPubMed Roch A, Allardet-Servent J, Michelet P, Oddoze C, Forel JM, Barrau K, Loundou A, Perrin G, Auffray JP, Portugal H, Papazian L: NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 2005, 33: 1001-1007. 10.1097/01.CCM.0000162561.82012.E9CrossRefPubMed
8.
Zurück zum Zitat Tomaru Ki K, Arai M, Yokoyama T, Aihara Y, Sekiguchi Ki K, Tanaka T, Nagai R, Kurabayashi M: Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol 2002, 34: 649-659. 10.1006/jmcc.2002.2005CrossRefPubMed Tomaru Ki K, Arai M, Yokoyama T, Aihara Y, Sekiguchi Ki K, Tanaka T, Nagai R, Kurabayashi M: Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol 2002, 34: 649-659. 10.1006/jmcc.2002.2005CrossRefPubMed
9.
Zurück zum Zitat Ma KK, Ogawa T, de Bold AJ: Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004, 36: 505-513. 10.1016/j.yjmcc.2004.01.001CrossRefPubMed Ma KK, Ogawa T, de Bold AJ: Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004, 36: 505-513. 10.1016/j.yjmcc.2004.01.001CrossRefPubMed
10.
Zurück zum Zitat Jardin F, Brun-Ney D, Auvert B, Beauchet A, Bourdarias JP: Sepsis-related cardiogenic shock. Crit Care Med 1990, 18: 1055-1060. 10.1097/00003246-199010000-00001CrossRefPubMed Jardin F, Brun-Ney D, Auvert B, Beauchet A, Bourdarias JP: Sepsis-related cardiogenic shock. Crit Care Med 1990, 18: 1055-1060. 10.1097/00003246-199010000-00001CrossRefPubMed
11.
Zurück zum Zitat Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser CA: Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997, 23: 553-560. 10.1007/s001340050372CrossRefPubMed Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser CA: Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997, 23: 553-560. 10.1007/s001340050372CrossRefPubMed
Metadaten
Titel
What does high NT-proBNP mean in septic shock patients? A part of the puzzle
Publikationsdatum
01.04.2007
Erschienen in
Critical Care / Ausgabe 2/2007
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc5728

Weitere Artikel der Ausgabe 2/2007

Critical Care 2/2007 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.